23 May 2013
Keywords: amgen, unveils, promising, pipeline, investors, remain, uncertain
Article | 05 April 2004
The USA's Amgen presented its full R&D pipeline of potential drugs last week, but its shares slumped as the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 April 2004
22 May 2013
© 2013 thepharmaletter.com